The standard of nutritional clinical research to substantiate claims for dietary supplements in the US has improved by “tremendously” in recent years, said a diverse panel of experts during the recent NutraIngredients-USA webinar.
Scientists at Duke University have received approval for a randomized, double blind, placebo-controlled clinical trial of probiotic Lacticaseibacillus rhamnosus GG (formerly Lactobacillus rhamnosus GG) in COVID-19 exposed households.
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
A new stakeholder group has come together to push for quality and transparency in the dietary supplement industry. Called the Dietary Supplement Quality Collaborative (DSQC), the group published a policy paper recently as part of its public debut.
Data collected over two years of post-market surveillance offers strong support for the safety and tolerability of PlusCBD products from CV Sciences, with fewer than 0.03% of products producing any kind of adverse event.
Supplement manufacturer NOW reports that among CoQ10 and SAMe products it purchased recently on Amazon and subjected to analytical testing, only a few came close to meeting label claim for the amount of active ingredients, while most had little or none...
Pharmavite, the manufacturer of Nature Made vitamins, has debuted nurish, a monthly vitamin subscription service based on individual data culled from an assessment that asks about life stage, diet, lifestyle, health and allergies.